Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

4.3K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Simplification of a Three-Constant Intraocular Lens Calculation Formula to a Single-Constant Approach: The Haigis Formula.

Diagnostics (Basel, Switzerland)·2026
Same author

Machine Learning-Based Prediction of Long-Term Intraocular Pressure Fluctuations in Open-Angle Glaucoma.

Ophthalmology science·2026
Same author

Intraocular Lens Calculation Concept Based on Aphakic Refraction-Considerations on a Cornea Model With Two Refracting Surfaces.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same author

Refractive and Corneal Astigmatism After Implantation of a Supraciliary Drainage Device in Microinvasive Glaucoma Surgery.

Journal of refractive surgery (Thorofare, N.J. : 1995)·2026
Same author

Correction: Prediction of the ectasia screening index from raw Casia2 volume data for keratoconus identification by using convolutional neural networks.

PloS one·2026
Same author

Response to the Letter to the Editor: Dual-Zone Keratometry for Identifying Central Radius and Corneal Asphericity.

Current eye research·2026

Related Experiment Video

Updated: Mar 19, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.3K

Growth Factor and Interleukin Concentrations in Amniotic Membrane-Conditioned Medium.

Mona Bischoff1,2, Tanja Stachon1, Berthold Seitz1,2

  • 1a Department of Ophthalmology , Saarland University Medical Center , Homburg/Saar , Germany.

Current Eye Research
|June 18, 2016
PubMed
Summary

Amniotic membrane-conditioned medium (AMM) eye drops show potential for treating corneal defects. Different preparation methods impact concentrations of epidermal growth factor (EGF), fibroblast growth factor basic (FGFb), IL-6, and IL-8, requiring further optimization.

Keywords:
Amniotic membrane conditioned mediumerosiongrowth factorinterleukintherapy-resistant corneal epithelial defects

More Related Videos

Preparation of Mouse Embryonic Fibroblast Cells Suitable for Culturing Human Embryonic and Induced Pluripotent Stem Cells
09:38

Preparation of Mouse Embryonic Fibroblast Cells Suitable for Culturing Human Embryonic and Induced Pluripotent Stem Cells

Published on: June 21, 2012

92.7K
In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane
10:00

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane

Published on: November 28, 2019

8.4K

Related Experiment Videos

Last Updated: Mar 19, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

10.3K
Preparation of Mouse Embryonic Fibroblast Cells Suitable for Culturing Human Embryonic and Induced Pluripotent Stem Cells
09:38

Preparation of Mouse Embryonic Fibroblast Cells Suitable for Culturing Human Embryonic and Induced Pluripotent Stem Cells

Published on: June 21, 2012

92.7K
In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane
10:00

In Vitro Culture of Epithelial Cells from Different Anatomical Regions of the Human Amniotic Membrane

Published on: November 28, 2019

8.4K

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Biochemistry

Background:

  • Therapy-resistant corneal epithelial defects pose a significant clinical challenge.
  • Amniotic membrane-conditioned medium (AMM) is being explored as a novel therapeutic agent.
  • AMM contains various growth factors and cytokines with potential regenerative properties.

Purpose of the Study:

  • To quantify the concentrations of key growth factors and interleukins in AMM.
  • To investigate the impact of different AMM preparation methods on these concentrations.
  • To assess the potential of AMM for treating corneal epithelial defects.

Main Methods:

  • Amniotic membranes from 10 placentas were processed and stored.
  • Membrane pieces were incubated in DMEM culture medium for varying durations (8 hours to 4 weeks).
  • Enzyme-linked immunosorbent assay (ELISA) was used to measure concentrations of EGF, NGF, VEGF, TGFβ1, FGFb, IL-1β, IL-6, and IL-8.

Main Results:

  • NGF, VEGF, TGFβ1, and IL-1β were below detection limits.
  • Detectable concentrations of EGF, FGFb, IL-6, and IL-8 were found.
  • Significant differences in IL-6 and IL-8 concentrations were observed between preparation methods at specific time points.

Conclusions:

  • AMM contains EGF, FGFb, IL-6, and IL-8, suggesting therapeutic potential for corneal defects.
  • Preparation methods significantly influence IL-6 and IL-8 levels.
  • Further research is needed to determine optimal preparation and harvesting times for AMM therapy.